Future of Dermatology / Skin Cancer

27 March 2026
Focus: Risk-Based Screening, Follow-up and Prevention

Context

Skin cancer represents a growing public health challenge and accounts for a substantial share of dermatological activity. The Working Group focused on ensuring that prevention, screening, and follow-up are organised in a way that safeguards early detection while using specialist capacity responsibly.

Key outcome

A national, risk-based guidance for skin cancer screening, follow-up, and prevention providing a framework for delivering the right level of care to the right patient at the right time. By supporting a more consistent and evidence-informed approach, it contributes to sustainable dermatological care while safeguarding quality and accessibility for patients at increased risk.

Key elements of the guidance

Clear, risk-based follow-up intervals tailored to individual risk profiles and cancer types.

Strong emphasis on patient education and self-inspection, supporting early detection while reducing reassurance-driven consultations.

Lesion-directed screening, focusing on lesions identified by the patient rather than systematic full body screening in low-risk individuals.

Reducing unnecessary consultations while safeguarding early detection through targeted assessment and risk classification.

Careful integration of digital tools, positioned as supportive aids under medical supervision.

Read more?